Baxter International Inc - Company Profile
Powered by 
All the sales intelligence you need on Baxter International Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Baxter International Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Baxter International Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Baxter International Inc (Baxter) is a medical technology company that develops, manufactures, and commercializes healthcare products and digital health solutions. The company offers sterile intravenous solutions, infusion systems, parenteral nutrition therapies, inhaled anaesthetics, and advanced surgical equipment. The company’s products find application in hospitals, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, and patients at home under physician supervision. Baxter distributes its products through direct sales force and a network of independent distributors, drug wholesalers, specialty pharmacies and other alternative site providers. The company has operations in the Americas, the Middle East, Africa, Europe, and Asia-Pacific. Baxter is headquartered in Deerfield, Illinois, the US.
Headquarters
United States of America
Address
One Baxter Parkway, Deerfield, Illinois, 60015
Website
www.baxter.com
Telephone
1 224 9482000
No of Employees
37,500
Industry
Medical Equipment
Ticker Symbol & Exchange
BAX (NYSE)
Revenue (2024)
$11.2B
5.7%
(2024 vs 2023)
EPS
XYZ
Net Income (2024)
XYZ
-47.5%
(2024 vs 2023)
Market Cap*
$11.0B
Net Profit Margin (2024)
XYZ
-39.5%
(2024 vs 2023)
* As of and is in US$
Baxter International Inc premium industry data and analytics
Products and Services
| Products | Services | Brands |
|---|---|---|
| Anaesthesia and Critical Care | Renal Care | Baxter |
| Advanced Surgery | Medication Delivery | Caelyx |
| Pharmaceutical Injectables | Clinical Nutrition | Doxil |
| XYZ | XYZ | XYZ |
| XYZ | XYZ | XYZ |
| XYZ | XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2026 | New Products/Services | In March, the company launched the IV Verify Line Labeling System, an automated solution. |
| 2026 | Contracts/Agreements | In January, the company entered into a partnership with MUSC Health to enhance patient care at MUSC Health using integrated connected-care technologies. |
| 2026 | New Products/Services | In January, the company introduced the Dynamo Series smart stretcher. |
Competitor Comparison
| Key Parameters | Baxter International Inc | Johnson & Johnson | Abbott Laboratories | Medtronic Plc | Fresenius Medical Care AG & Co KGaA |
|---|---|---|---|---|---|
| Headquarters | United States of America | United States of America | United States of America | Ireland | Germany |
| City | Deerfield | New Brunswick | Abbott Park | Dublin | Bad Homburg |
| State/Province | Illinois | New Jersey | Illinois | - | Hessen |
| No. of Employees | 37,500 | 138,200 | 115,000 | 95,000 | 11,513 |
| Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Andrew Hider | Interim President - Medical Products and Therapies; Chief Executive Officer; Director; President | Executive Board | 2025 | 49 |
| Charles Patel | Senior Vice President; Chief Information Officer | Senior Management | 2024 | - |
| James Borzi | Chief Supply Chain Officer; Executive Vice President | Senior Management | 2020 | 63 |
| Stacey Eisen | President - Baxter International Foundation; Chief Communications Officer and Corporate Marketing; Senior Vice President | Senior Management | 2024 | - |
| Cynthia Carlisle | Executive Vice President; Chief Human Resources Officer | Senior Management | 2026 | - |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer